Atorvastatin for Reduction of Myocardial Damage During Angioplasty - ARMYDA

Description:

The goal of the study was to evaluate the effect of pretreatment with atorvastatin compared with placebo in patients scheduled for elective percutaneous coronary intervention (PCI) on the risk of procedural myocardial injury.